• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination

tetano

Editor, Senior Moderator
Cell Rep Med


. 2024 Jul 25:101668.
doi: 10.1016/j.xcrm.2024.101668. Online ahead of print. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination

William N Voss[SUP] 1 [/SUP], Michael A Mallory[SUP] 2 [/SUP], Patrick O Byrne[SUP] 1 [/SUP], Jeffrey M Marchioni[SUP] 3 [/SUP], Sean A Knudson[SUP] 1 [/SUP], John M Powers[SUP] 2 [/SUP], Sarah R Leist[SUP] 2 [/SUP], Bernadeta Dadonaite[SUP] 4 [/SUP], Douglas R Townsend[SUP] 1 [/SUP], Jessica Kain[SUP] 1 [/SUP], Yimin Huang[SUP] 1 [/SUP], Ed Satterwhite[SUP] 5 [/SUP], Izabella N Castillo[SUP] 6 [/SUP], Melissa Mattocks[SUP] 6 [/SUP], Chelsea Paresi[SUP] 7 [/SUP], Jennifer E Munt[SUP] 2 [/SUP], Trevor Scobey[SUP] 2 [/SUP], Allison Seeger[SUP] 5 [/SUP], Lakshmanane Premkumar[SUP] 6 [/SUP], Jesse D Bloom[SUP] 8 [/SUP], George Georgiou[SUP] 5 [/SUP], Jason S McLellan[SUP] 1 [/SUP], Ralph S Baric[SUP] 9 [/SUP], Jason J Lavinder[SUP] 10 [/SUP], Gregory C Ippolito[SUP] 11 [/SUP]



Affiliations
Free article Abstract

We describe the molecular-level composition of polyclonal immunoglobulin G (IgG) anti-spike antibodies from ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, vaccination, or their combination ("hybrid immunity") at monoclonal resolution. Infection primarily triggers S2/N-terminal domain (NTD)-reactive antibodies, whereas vaccination mainly induces anti-receptor-binding domain (RBD) antibodies. This imprint persists after secondary exposures wherein >60% of ensuing hybrid immunity derives from the original IgG pool. Monoclonal constituents of the original IgG pool can increase breadth, affinity, and prevalence upon secondary exposures, as exemplified by the plasma antibody SC27. Following a breakthrough infection, vaccine-induced SC27 gained neutralization breadth and potency against SARS-CoV-2 variants and zoonotic viruses (half-maximal inhibitory concentration [IC[SUB]50[/SUB]] ∼0.1-1.75 nM) and increased its binding affinity to the protective RBD class 1/4 epitope (dissociation constant [K[SUB]D[/SUB]] < 5 pM). According to polyclonal escape analysis, SC27-like binding patterns are common in SARS-CoV-2 hybrid immunity. Our findings provide a detailed molecular definition of immunological imprinting and show that vaccination can produce class 1/4 (SC27-like) IgG antibodies circulating in the blood.

Keywords: COVID-19; Ig-seq; SARS-CoV-2; antibody feedback; bNAb; broadly neutralizing monoclonal antibody; cryo-EM; hybrid immunity; immunological imprinting; plasma.

 
Back
Top Bottom